Academic patents and access to medicines in developing countries
- PMID: 19008514
- PMCID: PMC2636619
- DOI: 10.2105/AJPH.2007.128769
Academic patents and access to medicines in developing countries
Abstract
There is a widespread and growing concern that patents hinder access to life-saving drugs in developing countries. Recent student movements and legislative initiatives emphasize the potential role that research universities in developed countries could have in ameliorating this "access gap." These efforts are based on the assumption that universities own patents on a substantial number of drugs and that patents on these drugs are currently filed in developing countries. I provide empirical evidence regarding these issues and explore the feasibility and desirability of proposals to change university patenting and licensing practices to promote access to medicines in the developing world.
Figures
Similar articles
-
TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.Chic J Int Law. 2002 Spring;3(1):27-46. Chic J Int Law. 2002. PMID: 15709298 No abstract available.
-
Introduction: Access to life-saving medicines and intellectual property rights.Camb Q Healthc Ethics. 2011 Apr;20(2):277-8. doi: 10.1017/S0963180110000927. Camb Q Healthc Ethics. 2011. PMID: 21435302 No abstract available.
-
The dilemma of intellectual property rights for pharmaceuticals: the tension between ensuring access of the poor to medicines and committing to international agreements.Dev World Bioeth. 2003 May;3(1):27-48. doi: 10.1111/1471-8847.00058. Dev World Bioeth. 2003. PMID: 14577451
-
Taking TRIPS to India--Novartis, patent law, and access to medicines.N Engl J Med. 2007 Feb 8;356(6):541-3. doi: 10.1056/NEJMp068245. N Engl J Med. 2007. PMID: 17287473 No abstract available.
-
Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity.Conn J Int Law. 2002 Spring;17(2):157-248. Conn J Int Law. 2002. PMID: 12688292 No abstract available.
Cited by 10 articles
-
TRIPS to Where? A Narrative Review of the Empirical Literature on Intellectual Property Licensing Models to Promote Global Diffusion of Essential Medicines.Pharmaceutics. 2021 Dec 27;14(1):48. doi: 10.3390/pharmaceutics14010048. Pharmaceutics. 2021. PMID: 35056944 Free PMC article. Review.
-
Structural violence and the biomedical innovation system: what responsibility do universities have in ensuring access to health technologies?BMJ Glob Health. 2021 May;6(5):e004916. doi: 10.1136/bmjgh-2020-004916. BMJ Glob Health. 2021. PMID: 33941514 Free PMC article. No abstract available.
-
The Current Status of Drug Discovery and Development as Originated in United States Academia: The Influence of Industrial and Academic Collaboration on Drug Discovery and Development.Clin Transl Sci. 2018 Nov;11(6):597-606. doi: 10.1111/cts.12577. Epub 2018 Jul 30. Clin Transl Sci. 2018. PMID: 29940695 Free PMC article.
-
Contribution of NIH funding to new drug approvals 2010-2016.Proc Natl Acad Sci U S A. 2018 Mar 6;115(10):2329-2334. doi: 10.1073/pnas.1715368115. Epub 2018 Feb 12. Proc Natl Acad Sci U S A. 2018. PMID: 29440428 Free PMC article.
-
NIH inventions translate into drugs and biologics with high public health impact.Nat Biotechnol. 2014 Jan;32(1):52-8. doi: 10.1038/nbt.2785. Nat Biotechnol. 2014. PMID: 24406928 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
